University of Washington, School of Pharmacy, Seattle, WA, USA.
University of Washington, School of Public Health, Seattle, WA, USA.
J Alzheimers Dis. 2019;68(2):523-529. doi: 10.3233/JAD-181080.
We administered a mixed-method survey to 1,661 patients in a large health system to assess preferences toward antihypertensive use for dementia prevention. If a specific antihypertensive medication was shown to prevent or delay dementia, the vast majority (>90%) of respondents currently taking an antihypertensive reported that they would be willing to take that specific antihypertensive starting as early as mid-life. Concerns reported were potential side effects, lack of evidence of effectiveness, blood pressure being normal or low, and medication cost. Analysis of free-text responses revealed themes of concerns regarding evidence of effectiveness and health priorities.
我们在一个大型医疗体系中对 1661 名患者进行了一项混合方法调查,以评估他们对使用抗高血压药物预防痴呆的偏好。如果某种特定的抗高血压药物被证明可以预防或延缓痴呆,那么绝大多数(>90%)目前正在服用抗高血压药物的受访者表示,他们愿意尽早从中年开始服用这种特定的抗高血压药物。报告的担忧包括潜在的副作用、缺乏有效性证据、血压正常或偏低以及药物费用。对自由文本回复的分析揭示了对有效性证据和健康优先事项的关注主题。